Resveratrol Protects against Methylglyoxal-Induced Hyperglycemia and Pancreatic Damage In Vivo
Open Access
- 15 April 2015
- Vol. 7 (4) , 2850-2865
Abstract
Methylglyoxal (MG) has been found to cause inflammation and insulin resistance in vitro and in vivo in recent studies. Resveratrol has been proposed as an effective treatment that helps lower the risk of developing complications of diabetes. To study the significance of glycosylation-related stress on the pathology of diabetes, the effects of resveratrol were examined in a mouse model of diabetes induced by MG. Resveratrol was given via oral gavage in MG-treated mice, and diabetes-related tests and markers were assessed using biochemical and immunohistochemical analyses. Treatment with resveratrol markedly improved blood glucose level from the oral glucose tolerance test and promoted nuclear factor erythroid 2-related factor-2 (Nrf2) phosphorylation (p < 0.05) in the pancreas of MG-treated mice. However, these effects were abolished by retinoic acid, Nrf2 inhibitor, in resveratrol and retinoic acid-treated and MG-induced mice. These findings support that resveratrol may be useful in the treatment of type-2 diabetes by protecting against pancreatic cell dysfunction.Keywords
This publication has 61 references indexed in Scilit:
- Dietary polyphenols as potential nutraceuticals in management of diabetes: a reviewJournal of Diabetes & Metabolic Disorders, 2013
- Antihyperglycemic Effects of Short Term Resveratrol Supplementation in Type 2 Diabetic PatientsEvidence-Based Complementary and Alternative Medicine, 2013
- Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinomaBMC Gastroenterology, 2012
- Hepatitis C virus E2 protein involve in insulin resistance through an impairment of Akt/PKB and GSK3β signaling in hepatocytesBMC Gastroenterology, 2012
- SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial FunctionCell Metabolism, 2012
- Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic NephropathyDiabetes, 2011
- Chronic Methylglyoxal Infusion by Minipump Causes Pancreatic β-Cell Dysfunction and Induces Type 2 Diabetes in Sprague-Dawley RatsDiabetes, 2011
- Alagebrium attenuates acute methylglyoxal‐induced glucose intolerance in Sprague‐Dawley ratsBritish Journal of Pharmacology, 2010
- Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alphaProceedings of the National Academy of Sciences, 2007
- Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetesNature, 2007